Loading organizations...
§ Private Profile · Cambridge, MA, USA
Poplar Therapeutics has raised $95.0M across 2 funding rounds.
Poplar Therapeutics has raised $95.0M in total across 2 funding rounds.
Poplar Therapeutics has raised $95.0M across 2 funding rounds. Most recently, it raised $45.0M Series A Extension in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 3, 2026 | $45M Series A Plus | DAN Lyons | ArrowMark Partners, RA Capital Management, SR ONE, Vida Ventures | Announced |
| Jan 7, 2026 | $50M Series A | Platanus, Jill Carroll, Helen KIM | — | Announced |
Poplar Therapeutics has raised $95.0M in total across 2 funding rounds.
Poplar Therapeutics's investors include Dan Lyons, ArrowMark Partners, RA Capital Management, SR One, Vida Ventures, Platanus, Jill Carroll, Helen Kim.